Hopeful new combo tested for Tough-to-Treat cancers
NCT ID NCT03711058
Summary
This study tested whether combining two drugs—copanlisib and nivolumab—could help control advanced cancers that had stopped responding to standard treatments. It focused on a specific type of colorectal cancer (called MSS) that is often resistant to immunotherapy. The main goals were to find a safe dose and see if the combination could shrink tumors or stop them from growing for at least six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNRESECTABLE OR METASTATIC MICROSATELLITE STABLE (MSS) SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21231, United States
Conditions
Explore the condition pages connected to this study.